Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care

Mannix, K.; Hjelmeland Ahmedzai, S.; Anderson, H.; Bennett, M.; Lloyd-Williams, M.; Wilcock, A.
November 2000
Palliative Medicine;Nov2000, Vol. 14 Issue 6, p455
Academic Journal
Abstract: This work was undertaken by the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) as a demonstration project in developing clinical guidelines relevant to palliative care from a pragmatic approach to literature review and grading of clinical evidence. CANCERLIT and Embase were searched for relevant papers written in English, published since 1980. Each study identified was rated against agreed criteria for levels of evidence. Most studies were not specifically designed to define speed of response, and were not undertaken in palliative care patients. Thus, careful reading and grading of each study was necessary. Sufficient evidence was identified to make recommendations for clinical practice in a palliative care population of patients, and areas for future research have been identified. Bisphosphonates appear to have a role in managing pain from metastases which has been refractory to conventional analgesic management and where oncological or orthopaedic intervention is delayed or inappropriate.


Related Articles

  • Biphosphonates spearhead new approach to treating bone metastases. Bankhead, Charles // JNCI: Journal of the National Cancer Institute;01/15/97, Vol. 89 Issue 2, p115 

    Focuses on the use of biphosphonates in treating bone metastasis. Relationship between tumor cells and bones; Biphosphonates' ability to inhibit crystal formation from calcium carbonate; Ability to increase bone mass by inhibiting resorption.

  • Osteonecrosis of the Jaw in Patients with Bone Metastases Treated with Bisphosphonates: A Retrospective Study. Ibrahim, Toni; Barbanti, Francesca; Giorgio-Marrano, Gianluca; Mercatali, Laura; Ronconi, Sonia; Vicini, Claudio; Amadori, Dino // Oncologist;Mar2008, Vol. 13 Issue 3, p330 

    Objective. Bone metastases are a major cause of morbidity in cancer patients. Treatment includes bisphosphonates, which are also associated with avascular osteonecrosis of the jaw (ONJ). Our aim was to evaluate the correlation between bisphosphonates and ONJ. Patients and Methods. Of the 539...

  • Klodronát … aneb stará láska nerezaví Vyuití u karcinomu prsu a karcinomu prostaty. ABRAHÁMOVÁ, J. // General Practitioner / Prakticky Lekar;May2011, Vol. 91 Issue 5, p278 

    The author resumes knowledge related to usage of bisphosphonates especially clodronate in the treatment of bone metastasis in malignant diseases. Clodronate is the first and currently longest used bisphosphonate in this indication. From realized trials with breast and prostate carcinoma results...

  • Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UK. Johnson, I.S. // Palliative Medicine;Mar2001, Vol. 15 Issue 2, p141 

    A postal survey of palliative physicians in the UK conducted in 1999 demonstrated widespread use of bisphosphonates for treatment of bone metastases from a variety of tumour types. In the absence of clear guidelines, however, there was found to be wide variation in treatment regimes, and...

  • Managing bone metastases in patients with breast cancer. Paterson, Alexander H.G. // Patient Care;2/1/1997, Vol. 31 Issue 2, p20 

    Focuses on the treatment and clinical problems presented by patients with bone metastases from breast cancer. How effete or damaged areas of bone are reabsorbed; Identification of the clinical problems in these patients; Indication that bisphosphonates have become a useful and adjunctive...

  • Treating bone metastases: Sparing the patient needless pain. McBride, Gail // JNCI: Journal of the National Cancer Institute;03/19/97, Vol. 89 Issue 6, p418 

    Reports on the need for oncologists to focus more on the proper treatment of bone metastases. Using biphosphonates in conjunction with chemotherapy; Criticizing the administration of localized radiation therapy; Referring patients for radiation therapy.

  • Metastatic disease of the skeleton. Buckwalter, Joseph A.; Brandser, Eric A. // American Family Physician;4/1/1997, Vol. 55 Issue 5, p1761 

    Discusses the metastatic cancer, the most frequent causes of skeletal pain associated with a destructive bone lesion or pathologic fracture in adults. Clinical presentation and differential diagnosis of metastatic disease; Imaging studies and evaluation of skeletal metastases; Evaluation of...

  • The Utility of Bisphosphonates in Kidney Cancer: Safety and Tolerability. Welsh, Liam; Khoo, Vincent // Current Medical Literature: Urology;2009, Vol. 15 Issue 1, p1 

    The article reviews available data on the safety and tolerability of biphosphonate therapy in kidney cancer. The rationale for biphosphonate therapy is explored. It explains in detail the mechanism of action of bisphosphonates. It references results from clinical trials demonstrating a benefit...

  • Prevention and Treatment of Bone Metastases. Woodward, E. J.; Coleman, R. E. // Current Pharmaceutical Design;9/11/2010, Vol. 16 Issue 27, p2998 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics